GDM is associated with reduced adipocyte differentiation and increased adipocyte size (hypertrophy), accompanied by downregulated gene expression of insulin signaling regulators, fatty acid transporters, and key adipogenic transcription factors, such as PPARγ [113]. The gene discussed is INS; the disease is gestational diabetes.